Brian W.  Ellis net worth and biography

Brian Ellis Biography and Net Worth

SVP of Danaher
Brian Ellis joined Danaher as Senior Vice President and General Counsel in January 2016, bringing a wealth of experience leading and developing global legal teams and supporting business growth.  

Brian leads Danaher’s global legal organization and ensures a strong culture of integrity and compliance. His areas of responsibility including corporate governance, quality assurance and regulatory affairs, sustainability, intellectual property and risk management as well as the company’s environment, health and safety group.

Brian was most recently General Counsel of Medtronic’s Restorative Therapies Group. In previous roles, he served as Chief Compliance Officer, and later General Counsel of Monitoring Solutions and Services, at GE Healthcare. Early in his career, he was a partner in private law firms and an Assistant U.S. Attorney for the Northern District of Illinois.

Brian received his undergraduate degree from Lake Forest College and his J.D. from University of Illinois College of Law. He lives in Bethesda, Maryland with his wife, Jeanette, and three children.

What is Brian W. Ellis' net worth?

The estimated net worth of Brian W. Ellis is at least $4.89 million as of July 25th, 2024. Mr. Ellis owns 20,230 shares of Danaher stock worth more than $4,894,466 as of January 17th. This net worth evaluation does not reflect any other investments that Mr. Ellis may own. Additionally, Mr. Ellis receives an annual salary of $1,930,000.00 as SVP at Danaher. Learn More about Brian W. Ellis' net worth.

How old is Brian W. Ellis?

Mr. Ellis is currently 57 years old. There are 7 older executives and no younger executives at Danaher. The oldest executive at Danaher is Mr. Steven M. Rales, Co-Founder & Chairman, who is 73 years old. Learn More on Brian W. Ellis' age.

What is Brian W. Ellis' salary?

As the SVP of Danaher Co., Mr. Ellis earns $1,930,000.00 per year. There are 4 executives that earn more than Mr. Ellis. The highest earning executive at Danaher is Mr. Rainer M. Blair, President, CEO & Director, who commands a salary of $5,330,000.00 per year. Learn More on Brian W. Ellis' salary.

How do I contact Brian W. Ellis?

The corporate mailing address for Mr. Ellis and other Danaher executives is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. Danaher can also be reached via phone at (202) 828-0850 and via email at investor.relations@danaher.com. Learn More on Brian W. Ellis' contact information.

Has Brian W. Ellis been buying or selling shares of Danaher?

Brian W. Ellis has not been actively trading shares of Danaher over the course of the past ninety days. Most recently, Brian W. Ellis sold 9,600 shares of the business's stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $275.16, for a transaction totalling $2,641,536.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares of the company's stock, valued at $5,566,486.80. Learn More on Brian W. Ellis' trading history.

Who are Danaher's active insiders?

Danaher's insider roster includes Rainer Blair (President, CEO & Director), Daniel Comas (EVP), Georgeann Couchara (SVP), William Daniel (EVP), Brian Ellis (SVP), Linda Filler (Director), Jose-Carlos Gutierrez-Ramos (SVP), Linda Hefner (Director), Jennifer Honeycutt (EVP), Thomas Joyce, Jr. (CEO), William King (SVP), Angela Lalor (SVP), Angela Lalor (SVP), Teri List (Director), Walter Lohr (Director), Robert Lutz (CAO), Matthew McGrew (CFO), Mitchell Rales (Chairman), Daniel Raskas (SVP), John Schwieters (Director), Alan Spoon (Director), Raymond Stevens (Director), Joakim Weidemanis (EVP), and Elias Zerhouni (Director). Learn More on Danaher's active insiders.

Are insiders buying or selling shares of Danaher?

In the last twelve months, insiders at the conglomerate sold shares 16 times. They sold a total of 221,399 shares worth more than $56,844,951.46. The most recent insider tranaction occured on August, 26th when SVP Georgeann Couchara sold 952 shares worth more than $255,488.24. Insiders at Danaher own 10.9% of the company. Learn More about insider trades at Danaher.

Information on this page was last updated on 8/26/2024.

Brian W. Ellis Insider Trading History at Danaher

See Full Table

Brian W. Ellis Buying and Selling Activity at Danaher

This chart shows Brian W Ellis's buying and selling at Danaher by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$2M-$1M$0$1M$2MTotal Insider BuyingTotal Insider Selling

Danaher Company Overview

Danaher logo
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.
Read More

Today's Range

Now: $241.94
Low: $234.60
High: $242.11

50 Day Range

MA: $235.07
Low: $226.16
High: $246.10

2 Week Range

Now: $241.94
Low: $222.53
High: $281.70

Volume

3,148,897 shs

Average Volume

2,640,177 shs

Market Capitalization

$174.75 billion

P/E Ratio

46.17

Dividend Yield

0.46%

Beta

0.83